Tuesday, March 06, 2018 8:26:15 PM
Remember do your own d.d.
My posts are of my opinion and the stocks i own have not made me rich. not yet
Recent THTX News
- Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders • GlobeNewswire Inc. • 04/15/2024 08:15:00 PM
- Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Theratechnologies Reports Financial Results and Provides Business Update for First Quarter 2024 • GlobeNewswire Inc. • 04/10/2024 11:30:00 AM
- U.S. Index Futures Show Mixed Trend Ahead of Key Inflation Data Release, Oil Prices Edge Higher • IH Market News • 04/10/2024 11:15:25 AM
- Theratechnologies Preclinical Data Presentation at AACR 2024 Highlights Versatility and Flexibility of SORT1+ Technology™ Oncology Platform • GlobeNewswire Inc. • 04/08/2024 08:30:00 PM
- Theratechnologies Appoints Elina Tea to its Board of Directors • GlobeNewswire Inc. • 04/05/2024 03:00:00 PM
- Theratechnologies to Announce First Quarter 2024 Financial Results and Provide Business Update • GlobeNewswire Inc. • 04/03/2024 11:30:00 AM
- Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform • GlobeNewswire Inc. • 03/28/2024 11:30:00 AM
- Theratechnologies Announces Update on its Preclinical Oncology Research Program • GlobeNewswire Inc. • 03/22/2024 01:36:29 PM
- Theratechnologies Appoints Jordan Zwick to its Board of Directors • GlobeNewswire Inc. • 03/22/2024 12:00:00 AM
- Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer • GlobeNewswire Inc. • 03/21/2024 11:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/29/2024 09:55:25 PM
- Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau • GlobeNewswire Inc. • 02/29/2024 09:34:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/27/2024 01:37:28 PM
- Theratechnologies Receives Refusal to File Letter for Trogarzo® Intramuscular Method of Administration sBLA from FDA • GlobeNewswire Inc. • 02/27/2024 12:30:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/21/2024 01:01:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/21/2024 01:00:27 PM
- Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance • GlobeNewswire Inc. • 02/21/2024 12:30:00 PM
- Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action • GlobeNewswire Inc. • 02/20/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/15/2024 01:36:56 PM
- Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer • GlobeNewswire Inc. • 02/15/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/06/2024 07:29:27 PM
- Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update • GlobeNewswire Inc. • 02/06/2024 12:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/01/2024 04:50:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM